| 回到 StockQ 正常版首頁 |
|
| 技術線圖 |
| 5日平均 | 10日平均 | 20日平均 |
| 14053.82 | 14248.64 | 14192.89 |
| 60日平均 | 120日平均 | 260日平均 |
| 13914.93 | 13525.08 | 11986.82 |
| Date | Price | Change% |
| 2026/03/09 | 14067.503 | -0.74% |
| 2026/03/06 | 14172.627 | 0.59% |
| 2026/03/05 | 14088.839 | 1.23% |
| 2026/03/04 | 13917.752 | -0.75% |
| 2026/03/03 | 14022.392 | -3.07% |
| 2026/03/02 | 14465.788 | -0.20% |
| 2026/02/27 | 14495.093 | -0.06% |
| 2026/02/26 | 14503.786 | 0.30% |
| 2026/02/25 | 14461.03 | 1.19% |
| 2026/02/24 | 14291.565 | 0.18% |
| 2026/02/23 | 14265.518 | 1.17% |
| 2026/02/13 | 14100.189 | -1.28% |
| 2026/02/12 | 14282.998 | 0.86% |
| 2026/02/11 | 14160.934 | -0.35% |
| 2026/02/10 | 14210.626 | 0.02% |
| 2026/02/09 | 14208.436 | 2.17% |
| 2026/02/06 | 13906.734 | -0.33% |
| 2026/02/05 | 13952.712 | -1.44% |
| 2026/02/04 | 14156.273 | 0.21% |
| 2026/02/03 | 14127.105 | 2.19% |
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 深證成指 | 9.17% | 6.76% | 26.43% | 4.78% |
| 聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
| 聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
| 聯博中國A股基金-A2類型/台幣 | 7.52% | 15.35% | 28.17% | 3.35% |
| 聯博中國A股基金-A2類型/美元 | 6.08% | 11.43% | 32.78% | 2.53% |
| 聯博中國A股基金-A2類型/人民幣 | 3.55% | 7.76% | 26.09% | 1.27% |
| 富達中國聚焦基金/美元 | -3.49% | 0.01% | 9.49% | -0.95% |
| 法巴中國股票基金-C股/美元 | 18.77% | 22.80% | 31.79% | 18.92% |
| 安聯中國策略基金/台幣 | 8.35% | 19.64% | 34.05% | 3.77% |
| 安聯中國股票基金-A股/配息/美元 | -3.46% | -2.39% | 9.54% | -0.04% |
| 霸菱香港中國基金-A類/配息/歐元 | -1.76% | 2.82% | -2.57% | 0.37% |
| 霸菱香港中國基金-A類/配息/美元 | -2.46% | 1.67% | 4.32% | -1.21% |
| 霸菱香港中國基金-A類/配息/英鎊 | -2.31% | 2.88% | 0.88% | -0.20% |
| 貝萊德中國基金A2/美元 | -2.65% | -1.37% | 1.10% | -1.61% |
| 貝萊德中國基金A2-歐元避險 | -3.20% | -2.49% | -1.36% | -2.09% |
| 貝萊德中國基金A2-澳幣避險 | -2.94% | -1.89% | -0.82% | -1.89% |
| 群益華夏盛世基金/台幣 | 8.13% | 17.34% | 22.83% | 5.43% |
| 群益華夏盛世基金/美元 | 6.67% | 13.37% | 27.25% | 4.60% |
| 群益華夏盛世基金/人民幣 | 4.12% | 9.62% | 20.91% | 3.21% |
| 群益中國新機會基金/台幣 | 12.98% | 14.23% | 25.49% | 9.25% |
| 群益中國新機會基金/美元 | 11.47% | 10.35% | 30.07% | 8.43% |
| 群益中國新機會基金/人民幣 | 8.81% | 6.70% | 23.59% | 6.99% |
| DWS投資中國股票基金E2/美元 | 3.65% | 17.91% | 23.93% | 15.77% |
| DWS投資中國股票基金A2/美元 | 14.96% | 19.61% | 24.27% | 15.09% |
| DWS投資中國股票基金FC/歐元 | -2.39% | 3.13% | 13.75% | 2.31% |
| DWS投資中國股票基金LC/歐元 | 8.52% | 5.45% | 15.14% | 2.42% |
| 瀚亞中國基金/台幣 | -1.93% | 3.68% | 27.23% | -3.83% |
| 瀚亞中國股票基金/美元 | -6.97% | -3.06% | 7.20% | -6.49% |
| 愛德蒙得洛希爾中國基金(A)/歐元 | -1.76% | 3.10% | 23.33% | 2.06% |
| 愛德蒙得洛希爾中國基金(A)/美元 | 3.84% | 17.76% | 34.15% | 15.82% |
| 歐義銳榮中國股票基金-R/歐元 | -6.15% | -3.65% | -1.35% | -3.30% |
| 歐義銳榮中國股票基金-R2/美元 | -6.68% | -4.92% | 6.15% | -4.64% |
| 首域盈信中國核心基金/美元 | 9.16% | 12.40% | 18.57% | 6.94% |
| 富蘭克林華美中國消費基金/台幣 | 3.60% | 6.66% | 12.55% | 1.36% |
| 富蘭克林華美中國傘型基金之中國A股基金/台幣 | 8.23% | 12.03% | 16.76% | 5.52% |
| 富蘭克林華美中國傘型基金之中國A股基金/人民幣 | 4.54% | 5.26% | 15.70% | 3.83% |
| 富蘭克林華美中國傘型基金之中國A股基金/美元 | 6.73% | 8.27% | 20.90% | 4.60% |
| 復華華人世紀基金/台幣 | 29.44% | 51.89% | 106.07% | 24.17% |
| 復華大中華中小策略基金/台幣 | 23.54% | 38.82% | 51.53% | 18.01% |
| 匯豐中國動力基金-台幣 | 10.89% | 22.99% | 34.09% | 6.86% |
| 匯豐中國股票基金AD/美元 | 13.70% | 18.83% | 17.02% | 13.93% |
| 景順中國基金-A股/美元 | -4.77% | -0.77% | 3.51% | -2.89% |
| 景順中國基金-A股/歐元對沖 | -5.41% | -2.10% | 0.88% | -3.39% |
| 景順中國基金-A股/澳幣對沖 | -5.02% | -1.38% | 1.62% | -3.09% |
| 摩根中國基金-A股/分派/美元 | -2.26% | 0.38% | 6.11% | -1.45% |
| 木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
| 木星中國基金–ACC/英鎊 | 13.43% | 16.64% | 37.41% | 13.75% |
| 野村中國機會基金/台幣 | 11.78% | 14.16% | 20.89% | 6.41% |
| 鋒裕匯理-中國股票基金-A2/美元 | 4.07% | 17.28% | 24.44% | 15.57% |
| 鋒裕匯理-中國股票基金-B2/美元 | 3.90% | 16.86% | 23.56% | 15.21% |
| 鋒裕匯理-中國股票基金-A2/歐元 | -1.77% | 2.48% | 14.18% | 1.67% |
| 荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
| 荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
| 新光中國成長基金/台幣 | 9.38% | 25.75% | 18.20% | 17.32% |
| 瑞銀(盧森堡)中國精選股票基金/美元 | -6.88% | -5.25% | 5.97% | -4.62% |
| 瑞銀(盧森堡)中國精選股票基金-月配息/美元 | -7.35% | -6.19% | 3.90% | -4.94% |
| 元大新中國基金/台幣 | 6.63% | 16.26% | 15.53% | 3.79% |
| ( 中國基金 ) | 3.36% | 7.91% | 15.83% | 3.25% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|